Athanase Innovation AB (ATIN) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.077x

Based on the latest financial reports, Athanase Innovation AB (ATIN) has a cash flow conversion efficiency ratio of -0.077x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-31.25 Million ≈ $-3.36 Million USD) by net assets (Skr405.72 Million ≈ $43.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Athanase Innovation AB for the company's overall valuation and market capitalisation.

Athanase Innovation AB - Cash Flow Conversion Efficiency Trend (2018–2026)

This chart illustrates how Athanase Innovation AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Athanase Innovation AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Athanase Innovation AB ranked by their cash flow conversion efficiency. Explore Athanase Innovation AB cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Sachem Capital Corp
NYSE MKT:SACH
-0.017x
Daehan New Pharm Co. Ltd
KQ:054670
0.034x
Gihon Telekomunikasi Indonesia Tbk PT
JK:GHON
0.046x
Energia Latina SA
SN:ENLASA
0.077x
International Conveyors Limited
NSE:INTLCONV
-0.015x
Hansol Csn
KO:009180
0.030x
Somnomed Ltd
AU:SOM
0.083x
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
-0.096x

Annual Cash Flow Conversion Efficiency for Athanase Innovation AB (2018–2026)

The table below shows the annual cash flow conversion efficiency of Athanase Innovation AB from 2018 to 2026. View Athanase Innovation AB stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-06-30 Skr427.41 Million
≈ $46.00 Million
Skr-65.63 Million
≈ $-7.06 Million
-0.154x -397.70%
2025-06-30 Skr484.76 Million
≈ $52.17 Million
Skr-14.96 Million
≈ $-1.61 Million
-0.031x +76.54%
2024-06-30 Skr634.09 Million
≈ $68.24 Million
Skr-83.40 Million
≈ $-8.98 Million
-0.132x -138.64%
2023-06-30 Skr791.89 Million
≈ $85.22 Million
Skr-43.65 Million
≈ $-4.70 Million
-0.055x -235.90%
2022-06-30 Skr907.40 Million
≈ $97.65 Million
Skr-14.89 Million
≈ $-1.60 Million
-0.016x -100.27%
2021-06-30 Skr3.73 Million
≈ $401.95K
Skr23.10 Million
≈ $2.49 Million
6.185x +6656.90%
2020-06-30 Skr244.06 Million
≈ $26.26 Million
Skr22.34 Million
≈ $2.40 Million
0.092x -16.01%
2019-06-30 Skr260.43 Million
≈ $28.03 Million
Skr28.38 Million
≈ $3.05 Million
0.109x +100.30%
2018-06-30 Skr276.69 Million
≈ $29.78 Million
Skr15.05 Million
≈ $1.62 Million
0.054x --

About Athanase Innovation AB

ST:ATIN Sweden Asset Management
Market Cap
$52.76 Million
Skr490.27 Million SEK
Market Cap Rank
#21788 Global
#397 in Sweden
Share Price
Skr20.20
Change (1 day)
-0.98%
52-Week Range
Skr12.00 - Skr21.60
All Time High
Skr2115.29
About

Athanase Innovation AB is public venture capital firm specializing in seed funding. The firm primarily invests in private and public technology and innovation companies. It also develops and sells machine inspection unit, used for automatic quality control, inspection and measurement of pallets. The firm typically invests in companies in US and Nordic markets. Athanase Innovation AB was founded i… Read more